Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · ResMed (RMD)

ResMed Reports Q1 Fiscal 2027 Revenue of $1.4 Billion and Declares Dividend

Positive Impact 3 of 5 earnings

ResMed Inc. reported first-quarter fiscal year 2027 revenue of $1.4 billion, representing a 6% increase compared to the prior-year period. GAAP diluted earnings per share rose 23% to $2.92, while the board declared a quarterly cash dividend of $0.66 per share.

Key points

  • Q1 revenue increased 6% to $1.4 billion, or 7% on a core constant currency basis.
  • GAAP diluted earnings per share grew 23% to $2.92, and non-GAAP diluted EPS rose 14% to $2.91.
  • The board of directors declared a quarterly cash dividend of $0.66 per share, payable on December 17, 2026, with a record date of November 12, 2026.
  • The company returned more than $1.0 billion to shareholders through share repurchases and dividends during the quarter.

The filing

CompanyResMed (RMD)
Form8-K, current report
Filed with the SECOct 29, 2026, 4:05 PM ET
Accession number0001193125-26-437783

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Oct 30, 2026, 8:17 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.